1 active warrant series covering 23,253,480 shares (~7.5% potential dilution); nearest expiry 2032-12-31.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $4.18 | Dec 31, 2032 2284d | 23.3M | OTM | 7.5% | $97.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 14,137,726 shares (~4.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.95 | Mar 31, 2032 2009d | 14.1M | OTM | 4.6% | $13.4M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
309,561,287 shares outstanding, plus 23,253,480 from warrants and 14,137,726 from options — a fully diluted 346,952,493 shares, or ~12.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
1 active warrant series covering 23,253,480 shares (~7.5% potential dilution); nearest expiry 2032-12-31.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $4.18 | Dec 31, 2032 2284d | 23.3M | OTM | 7.5% | $97.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 14,137,726 shares (~4.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.95 | Mar 31, 2032 2009d | 14.1M | OTM | 4.6% | $13.4M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
309,561,287 shares outstanding, plus 23,253,480 from warrants and 14,137,726 from options — a fully diluted 346,952,493 shares, or ~12.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
